74 related articles for article (PubMed ID: 10923105)
1. Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors.
Apfel SC
Cancer Invest; 2000; 18(6):564-73. PubMed ID: 10923105
[No Abstract] [Full Text] [Related]
2. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
Hennequin C; Giocanti N; Favaudon V
Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
[TBL] [Abstract][Full Text] [Related]
3. Taxoids: a new class of cytotoxic agents.
Marty M; Extra JM; Giacchetti S; Cuvier C; Espie M
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S25-8. PubMed ID: 7909941
[TBL] [Abstract][Full Text] [Related]
4. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor prevention of aged-rat sympathetic neuron injury by cisplatin, vincristine and taxol--in vitro explant study.
Hayakawa K; Itoh T; Niwa H; Yamamoto M; Liang Y; Doyu M; Sobue G
Neurosci Lett; 1999 Oct; 274(2):103-6. PubMed ID: 10553948
[TBL] [Abstract][Full Text] [Related]
6. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
7. GDNF reduces apoptosis in dopaminergic neurons in vitro.
Clarkson ED; Zawada WM; Freed CR
Neuroreport; 1995 Dec; 7(1):145-9. PubMed ID: 8742438
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients resistant to paclitaxel therapy.
Valero V
Anticancer Drugs; 1996 Aug; 7 Suppl 2():17-9. PubMed ID: 8862705
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of Taxol and Taxotere analogues.
Guénard D; Guéritte-Voegelein F; Dubois J; Potier P
J Natl Cancer Inst Monogr; 1993; (15):79-82. PubMed ID: 7912533
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions.
Munkarah A; Chuang L; Lotzová E; Cook K; Morris M; Wharton JT
Gynecol Oncol; 1994 Nov; 55(2):211-6. PubMed ID: 7959286
[TBL] [Abstract][Full Text] [Related]
11. Taxoids in combination chemotherapy for metastatic breast cancer.
Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
[TBL] [Abstract][Full Text] [Related]
12. Conclusion: the place of docetaxel (Taxotere) in future therapy.
Khayat D
Anticancer Drugs; 1996 Aug; 7 Suppl 2():53. PubMed ID: 8862713
[No Abstract] [Full Text] [Related]
13. Docetaxel (Taxotere): a highly active taxoid with manageable toxicity.
Aapro MS
Semin Oncol; 1995 Apr; 22(2 Suppl 4):1-2. PubMed ID: 7740325
[No Abstract] [Full Text] [Related]
14. Taxoids: effective agents in anthracycline-resistant breast cancer.
Ravdin PM
Semin Oncol; 1995 Dec; 22(6 Suppl 13):29-34. PubMed ID: 8604450
[TBL] [Abstract][Full Text] [Related]
15. The clinical rationale for developing docetaxel (Taxotere).
Armand JP
Anticancer Drugs; 1996 Aug; 7 Suppl 2():37-9. PubMed ID: 8862710
[TBL] [Abstract][Full Text] [Related]
16. S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells.
Hennequin C; Giocanti N; Favaudon V
Br J Cancer; 1995 Jun; 71(6):1194-8. PubMed ID: 7779710
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel (Taxotere) for advanced breast cancer.
Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
[No Abstract] [Full Text] [Related]
18. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
Kris MG; Millward M
Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
[No Abstract] [Full Text] [Related]
19. Clinical trials referral resource. Clinical trials with Docetaxel (Taxotere).
Cheson BD; Arbuck SG; Phillips PH
Oncology (Williston Park); 1993 Sep; 7(9):51-2. PubMed ID: 8105859
[No Abstract] [Full Text] [Related]
20. Docetaxel (taxotere) in the treatment of prostate cancer.
Beer TM; El-Geneidi M; Eilers KM
Expert Rev Anticancer Ther; 2003 Jun; 3(3):261-8. PubMed ID: 12820771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
